2021
DOI: 10.1126/scitranslmed.abb3312
|View full text |Cite
|
Sign up to set email alerts
|

JUN promotes hypertrophic skin scarring via CD36 in preclinical in vitro and in vivo models

Abstract: JUN drives scarring by modifying the roles of fibroblast subpopulations, and JUN antagonism via CD36 may represent an antiscarring therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
20
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(21 citation statements)
references
References 69 publications
(82 reference statements)
1
20
0
Order By: Relevance
“…Previous studies have reported homozygous Jund −/− mutant male mice showed defective spermatogenesis and decreased fertility, and the knockout of c-Fos also blocked normal spermatogenesis [ 48 , 49 ]. JUN is an important component of the AP-1 complex, which is known for transcription activation, and also plays essentials roles in different biological processes, including the development of heart and liver, tissue scarring and others [ 50 52 ]. In fact, Jun −/− mice have demonstrated arrested embryonic development at E13 due to the failure of organ development [ 51 ].…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies have reported homozygous Jund −/− mutant male mice showed defective spermatogenesis and decreased fertility, and the knockout of c-Fos also blocked normal spermatogenesis [ 48 , 49 ]. JUN is an important component of the AP-1 complex, which is known for transcription activation, and also plays essentials roles in different biological processes, including the development of heart and liver, tissue scarring and others [ 50 52 ]. In fact, Jun −/− mice have demonstrated arrested embryonic development at E13 due to the failure of organ development [ 51 ].…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, administration with the nuclear Yap-TEAD inhibitor verteporfin prolonged myofibroblast persistence and converted tissue regeneration to fibrosis in vivo [ 69 ]. JUN initiates hypertrophic scar formation by regulating CD36, modulating distinct fibroblast subpopulations, boosting reticular fibroblasts, and decreasing levels of lipofibroblasts [ 70 ].…”
Section: Regulation Of Fibroblasts In Wound Healing and Scar Formationmentioning
confidence: 99%
“…The FB-1 in HS had a higher expression level of TWIST2 than that in NS ( Figure 7B , adjusted p -value < 0.05). The previous study identified JUN as a critical regulator by promoting hypertrophic skin scarring ( Griffin et al, 2021 ). Consistently, we also found that the transcriptional activity of JUN was higher in HS than NS ( Supplementary Figure S1 ).…”
Section: Resultsmentioning
confidence: 99%